The evolution of tools for protein phosphorylation site analysis: From discovery to clinical application

BioTechniques

Volumn 44, Issue 5, 2008, Pages 671-679

  Bonilla, Leo E ^a   Means, Gary D ^a   Lee, Kimberly A ^a   Patterson, Scott D ^b  

^a AMGEN INC   (United States)

^b AMGEN INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN;

FLOW CYTOMETRY; HISTORY; ISOTOPE LABELING; MASS SPECTROMETRY; MOLECULAR EVOLUTION; PROTEIN PHOSPHORYLATION; PROTEOMICS; REVIEW; TECHNOLOGY;

BINDING SITES; DRUG DESIGN; MASS SPECTROMETRY; PEPTIDE MAPPING; PHOSPHATES; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN INTERACTION MAPPING;

EID: 43249105735     PISSN: 07366205     EISSN: None     Source Type: Journal    
DOI: 10.2144/000112800     Document Type: Review

References (68)

1. Collins, M.O., L. Yu, and J.S. Choudhary. 2007. Analysis of protein phosphorylation on a proteome-scale. Proteomics 7:2751-2768.
2. Goshe, M.B. 2006. Characterizing phosphoproteins and phosphoproteomes using mass spectrometry. Brief. Funct. Genomics and Proteomics 4:363-376.
3. Lee, K.A., G.D. Means, and S.D. Patterson. 2006. Phosphoproteomics: challenges and opportunities. Current Proteomics 5:249-257.
4. Patterson, S.D. and J.I. Garrels. 1994. Two-dimensional gel analysis of posttranslational modifications, p. 249-257. In J.E. Celis (Ed.), Cell Biology: A Laboratory Handbook. Academic Press, New York.
5. Johnston, R.F., S.C. Pickett, and D.L. Barker. 1990. Autoradiography using storage phosphor technology. Electrophoresis 11:355-360.
6. Harrington, M.G., L. Hood, and C. Puckett. 1991. Simultaneous analysis of phosphoproteins and total cellular proteins from PC12 cells. Methods: Companion Methods Enzymol. 3:135-141.
7. Patterson, S.D. and G.I. Latter. 1993. Evaluation of storage phosphor imaging for quantitative analysis of 2-D gels using the Quest II system. BioTechniques 15:1076-1083.
8. Hildebrandt, E. and V.A. Fried. 1989. Phosphoamino acid analysis of protein immoblized on polyvinylidene difluoride membrane. Anal. Biochem. 177:407-412.
9. Boyle, W.J., P. van der Geer, and T. Hunter. 1991. Phosphopeptide mapping and phosphoamino acid analysis by two-dimensional separation on thin-layer cellulose plates. Methods Enzymol. 201:110-149.
10. Li, Y., T.J. Soos, X. Li, J. Wu, M. Degennaro, X. Sun, D.R. Littman, M.J. Birnbaum, and R.D. Polakiewicz. 2004. Protein kinase C Theta inhibits insulin signaling by phosphorylating IRS1 at Ser(1101). J. Biol. Chem. 279:45304-45307.
11. Morrison, D.K., G. Heidecker, U.R. Rapp, and T.D. Copeland. 1993. Identification of the major phosphorylation sites of the Raf-1 kinase. J. Biol. Chem. 268:17309-17316.
12. Patterson, S.D., R. Aebersold, and D.R. Goodlett. 2001. Mass spectrometry-based methods for protein identification and phosphorylation site analysis, p. 87-130. In S.R. Pennington and M.J. Dunn (Eds.), Proteomics: From Protein Sequence to Function. BIOS Scientific Publishers, Oxford, UK.
13. Aebersold, R. and S.D. Patterson. 1998. Current problems and technical solutions in protein biochemistry, p. 3-120. In R.H. Angeletti (Ed.), Proteins: Analysis & Design. Academic Press, San Diego, CA.
14. Alfonso, P., I. Dolado, A. Swat, A. Nunez, A. Cuadrado, A.R. Nebreda, and J.I. Casal. 2006. Proteomic analysis of p38alpha mitogen-activated protein kinase-regulated changes in membrane fractions of RAS-transformed fibroblasts. Proteomics 6:S262-S271.
15. Matis, M., M. Zakelj-Mavric, and J. Peter-Katalinic. 2005. Global analysis of the Hortaea werneckii proteome: studying steroid response in yeast. J. Proteome Res. 4:2043-2051.
16. Sitek, B., O. Apostolov, K. Stuhler, K. Pfeiffer, H.E. Meyer, A. Eggert, and A. Schramm. 2005. Identification of dynamic proteome changes upon ligand activation of Trk-receptors using two-dimensional fluorescence difference gel electrophoresis and mass spectrometry. Mol. Cell. Proteomics 4:291-299.
17. Ueda, K., H. Kosako, Y. Fukui, and S. Hattori. 2004. Proteomic identification of Bcl2-associated athanogene 2 as a novel MAPK-activated protein kinase 2 substrate. J. Biol. Chem. 279:41815-41821.
18. Irish, J.M., R. Hovland, P.O. Krutzik, O.D. Perez, O. Bruserud, B.T. Gjertsen, and G.P. Nolan. 2004. Single cell profiling of potentiated phospho-protein networks in cancer cells. Cell 118:217-228.
19. Aebersold, R. and M. Mann. 2003. Mass spectrometry-based proteomics. Nature 422:198-207.
20. Patterson, S.D. 2004. How much of the proteome do we see with discovery-based proteomics methods and how much do we need to see? Current Proteomics 1:3-12.
21. Patterson, S.D. and R.H. Aebersold. 2003. Proteomics: the first decade and beyond. Nat. Genet. 33:311-323.
22. Zhou, M. and T.D. Veenstra. 2008 Mass spectrometry: m/z 1983-2008. BioTechniques. 44:667-670.
23. Patterson, S.D. 2003. Proteomics: evolution of the technology. BioTechniques 35:440-444.
24. Carr, S.A., R.S. Annan, and M.J. Huddleston. 2005. Mapping posttranslational modifications of proteins by MS-based selective detection: application to phosphoproteomics. Methods Enzymol. 405:82-115.
25. Carr, S.A., M.J. Huddleston, and R.S. Annan. 1996. Selective detection and sequencing of phosphopeptides at the femtomole level by mass spectrometry. Anal. Biochem. 239:180-192.
26. Steen, H., B. Kuster, M. Fernandez, A. Pandey, and M. Mann. 2001. Detection of tyrosine phosphorylated peptides by precursor ion scanning quadrupole TOF mass spectrometry in positive ion mode. Anal. Chem. 73:1440-1448.
27. Hubbard, M.J. and P. Cohen. 1993. On target with a new mechanism for the regulation of protein phosphorylation. Trends Biochem. Sci. 18:172-177.
28. Hunter, T. and B.M. Sefton. 1980. Transforming gene product of Rous sarcoma virus phosphorylates tyrosine. Proc. Natl. Acad. Sci. USA 77:1311-1315.
29. Kmiecik, T.E. and D. Shalloway. 1987. Activation and suppression of pp60c-src transforming ability by mutation of its primary sites of tyrosine phosphorylation. Cell 49:65-73.
30. Salomon, A.R., S.B. Ficarro, L.M. Brill, A. Brinker, Q.T. Phung, C. Ericson, K. Sauer, A. Brock, et al. 2003. Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry. Proc. Natl. Acad. Sci. USA 100:443-448.
31. Posewitz, M.C. and P. Tempst. 1999. Immobilized gallium(III) affinity chromatography of phosphopeptides. Anal. Chem. 71:2883-2892.
32. Ficarro, S.B., M.L. McCleland, P.T. Stukenberg, D.J. Burke, M.M. Ross, J. Shabanowitz, D.F. Hunt, and F.M. White. 2002. Phosphoproteome analysis by mass spectrometry and its application to Saccharomyces cerevisiae. Nat. Biotechnol. 20:301-305.
33. He, T., K. Alving, B. Feild, J. Norton, E.G. Joseloff, S.D. Patterson, and B. Domon. 2004. Quantitation of phosphopeptides using affinity chromatography and stable isotope labeling. J. Am. Soc. Mass Spectrom. 15:363-373.
34. Pinkse, M.W., P.M. Uitto, M.J. Hilhorst, B. Ooms, and A.J. Heck. 2004. Selective isolation at the femtomole level of phosphopeptides from proteolytic digests using 2D-NanoLC-ESI-MS/MS and titanium oxide precolumns. Anal. Chem. 76:3935-3943.
35. Larsen, M.R., T.E. Thingholm, O.N. Jensen, P. Roepstorff, and T.J. Jorgensen. 2005. Highly selective enrichment of phosphorylated peptides from peptide mixtures using titanium dioxide microcolumns. Mol. Cell. Proteomics 4:873-886.
36. Beausoleil, S.A., M. Jedrychowski, D. Schwartz, J.E. Elias, J. Villen, J. Li, M.A. Cohn, L.C. Cantley, et al. 2004. Large-scale characterization of HeLa cell nuclear phosphoproteins. Proc. Natl. Acad. Sci. USA 101:12130-12135.
37. Gruhler, A., J.V. Olsen, S. Mohammed, P. Mortensen, N.J. Faergeman, M. Mann, and O.N. Jensen. 2005. Quantitative phosphoproteomics applied to the yeast pheromone signaling pathway. Mol. Cell. Proteomics 4:310-327.
38. Wagner, K., K. Edson, L. Heginbotham, M. Post, R.L. Huganir, and A.J. Czernik. 1991. Determination of the tyrosine phosphorylation sites of the nicotinic acetylcholine receptor. J. Biol. Chem. 266:23784-23789.
39. Lombardo, C.R., T.G. Consler, and D.B. Kassel. 1995. In vitro phosphorylation of the epidermal growth factor receptor autophosphorylation domain by c-src: identification of phosphorylation sites and c-src SH2 domain binding sites. Biochemistry 34:16456-16466.
40. Zhao, Y. and B.T. Chait. 1994. Protein epitope mapping by mass spectrometry. Anal. Chem. 66:3723-3726.
41. De Corte, V., H. Demol, M. Goethals, J. Van Damme, J. Gettemans, and J. Vandekerckhove. 1999. Identification of Tyr438 as the major in vitro c-Src phosphorylation site in human gelsolin: a mass spectrometric approach. Protein Sci. 8:234-241.
42. Rush, J., A. Moritz, K.A. Lee, A. Guo, V.L. Goss, E.J. Spek, H. Zhang, X.M. Zha, et al. 2005. Immunoaffinity profiling of tyrosine phosphorylation in cancer cells. Nat. Biotechnol. 23:94-101.
43. Goshe, M.B., T.P. Conrads, E.A. Panisko, N.H. Angell, T.D. Veenstra, and R.D. Smith. 2001. Phosphoprotein isotope-coded affinity tag approach for isolating and quantitating phosphopeptides in proteome-wide analyses. Anal. Chem. 73:2578-2586.
44. McLachlin, D.T. and B.T. Chait. 2003. Improved beta-elimination-based affinity purification strategy for enrichment of phosphopeptides. Anal. Chem. 75:6826-6836.
45. Qian, W.J., M.B. Goshe, D.G. Camp II, L.R. Yu, K. Tang, and R.D. Smith. 2003. Phosphoprotein isotope-coded solid-phase tag approach for enrichment and quantitative analysis of phosphopeptides from complex mixtures. Anal. Chem. 75:5441-5450.
46. Resing, K.A., R.S. Johnson, and K.A. Walsh. 1995. Mass spectrometric analysis of 21 phosphorylation sites in the internal repeat of rat profilaggrin, precursor of an intermediate filament associated protein. Biochemistry 34:9477-9487.
47. Thompson, A.J., S.R. Hart, C. Franz, K. Barnouin, A. Ridley, and R. Cramer. 2003. Characterization of protein phosphorylation by mass spectrometry using immobilized metal ion affinity chromatography with on-resin beta-elimination and Michael addition. Anal. Chem. 75:3232-3243.
48. Weckwerth, W., L. Willmitzer, and O. Fiehn. 2000. Comparative quantification and identification of phosphoproteins using stable isotope labeling and liquid chromatography/mass spectrometry. Rapid Commun. Mass Spectrom. 14:1677-1681.
49. Janek, K., H. Wenschuh, M. Bienert, and E. Krause. 2001. Phosphopeptide analysis by positive and negative ion matrix-assisted laser desorption/ionization mass spectrometry. Rapid Commun. Mass Spectrom. 15:1593-1599.
50. Lee, K.A., K.B. Craven, G.A. Niemi, and J.B. Hurley. 2002. Mass spectrometric analysis of the kinetics of in vivo rhodopsin phosphorylation. Protein Sci. 11:862-874.
51. Cooper, H.J., K. Hakansson, and A.G. Marshall. 2005. The role of electron capture dissociation in biomolecular analysis. Mass Spectrom. Rev. 24:201-222.
52. Coon, J.J., J. Shabanowitz, D.F. Hunt, and J.E. Syka. 2005. Electron transfer dissociation of peptide anions. J. Am. Soc. Mass Spectrom. 16:880-882.
53. Syka, J.E., J.J. Coon, M.J. Schroeder, J. Shabanowitz, and D.F. Hunt. 2004. Peptide and protein sequence analysis by electron transfer dissociation mass spectrometry. Proc. Natl. Acad. Sci. USA 101:9528-9533.
54. MacCoss, M.J., W.H. McDonald, A. Saraf, R. Sadygov, J.M. Clark, J.J. Tasto, K.L. Gould, D. Wolters, et al. 2002. Shotgun identification of protein modifications from protein complexes and lens tissue. Proc. Natl. Acad. Sci. USA 99:7900-7905.
55. Roth, M.J., A.J. Forbes, M.T. Boyne II, Y.B. Kim, D.E. Robinson, and N.L. Kelleher. 2005. Precise and parallel characterization of coding polymorphisms, alternative splicing, and modifications in human proteins by mass spectrometry. Mol. Cell. Proteomics 4:1002-1008.
56. LeDuc, R.D., G.K. Taylor, Y.-B. Kim, T.E. Januszyk, L.H. Bynum, J.V. Sola, J.S. Garavelli, and N.L. Kelleher. 2004. ProSight PTM: an integrated environment for protein identification and characterization by top-down mass spectrometry. Nucleic Acids Res. 32:W340-W345.
57. Bruce, C., M.A. Shifman, P. Miller, and E.E. Gulcicek. 2006. Probabilistic enrichment of phosphopeptides by their mass defect. Anal. Chem. 78:4374-4382.
58. Wilkins, M.R., R.D. Appel, J.E. Van Eyk, M.C. Chung, A. Gorg, M. Hecker, L.A. Huber, H. Langen, et al. 2006. Guidelines for the next 10 years of proteomics. Proteomics 6:4-8.
59. Means, G.D. 2007. Quantitation of phosphoprotein biomarkers associated with inflammatory disease in whole blood. American Drug Discovery 2:24-28.
60. Zagursky, R.J., D. Sharp, K.A. Solomon, and A. Schwartz. 1995. Quantitation of cellular receptors by a new immunocytochemical flow cytometry technique. BioTechniques 18:504-509.
61. Piqueras, B., B. Autran, P. Debre, and G. Gorochov. 1996. Detection of apoptosis at the single-cell level by direct incorporation of fluorescein-dUTP in DNA strand breaks. BioTechniques 20:634-640.
62. Krutzik, P.O., J.M. Crane, M.R. Clutter, and G.P. Nolan. 2008. High-content single-cell drug screening with phosphospecific flow cytometry. Nat. Chem. Biol. 4:132-142.
63. Severino, M.E., R.F. Dubose, and S.D. Patterson. 2006. A strategic view on the use of pharmacodynamic biomarkers in early clinical drug development. IDrugs 9:849-853.
64. Covey, T., S. Mu, and C.J.M. Saris. 2005. Monitoring signal transduction in whole blood by flow cytometry, Abstract #LB531. FASEB Experimental Biology 2005. FASEB, San Diego, CA.
65. Danna, E.A. and G.P. Nolan. 2006. Transcending the biomarker mindset: deciphering disease mechanisms at the single cell level. Curr. Opin. Chem. Biol. 10:20-27.
66. Krutzik, P.O., J.M. Irish, G.P. Nolan, and O.D. Perez. 2004. Analysis of protein phosphorylation and cellular signaling events by flow cytometry: techniques and clinical applications. Clin. Immunol. 110:206-221.
67. Perez, O.D. and G.P. Nolan. 2006. Phospho-proteomic immune analysis by flow cytometry: from mechanism to translational medicine at the single-cell level. Immunol. Rev. 270:208-228.
68. McCaffery, I., V.D. Fitzpatrick, S.-W. Wang, J. Rossi, S.V. Suggs, H. Bao, J. Ferbas, and S.D. Patterson. 2008. Translation of protein biomarkers for clinical development, p. 633-651. In J.E. Van Eyk and M.J. Dunn (Eds.), Clinical Proteomics: From Diagnosis to Therapy. WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim, Germany.